Life sciences
Our specialist life sciences team understand the complex nature of the sector.
Time-to-market and funding are the crucial factors driving innovation and successful new pharmaceutical product launches, which in turn, require laboratories, vivaria, pilot plants and manufacturing facilities. Avison Young’s specialists understand the pharmaceutical product life cycle as well as the technical complexities that can create significant budgetary and scheduling risk.
We’ve successfully addressed the risks that surround real estate decision making throughout all phases of the product life cycle and across all technical aspects of planning, designing, engineering and constructing any type of life science space.

Life Sciences key contacts

News and updates
-
Strategic government intervention set to drive commercial real estate momentum, according to Avison Young Outlook report10 July 2025
-
Avison Young bolsters sustainability and decarbonisation team with senior appointments10 July 2025
-
Avison Young appoints Kat Hanna as head of UK Market Intelligence and Strategy to drive client insights08 July 2025
-
London Borough of Newham launches Grade II listed house and Epping Forest campsite to sale02 July 2025